eISSN 2097-6046
ISSN 2096-7446
CN 10-1655/R
Responsible Institution:China Association for Science and Technology
Sponsor:Chinese Nursing Association
Emergency Care Research

Nursing care of a patient undergoing emergency coronary intervention combined with left ventricular assist device therapy after cardiac arrest

  • MO Minhua ,
  • Lo Wan Po Joanna ,
  • Shum Hoi Ping ,
  • Chang Li Li
Expand

Received date: 2024-12-05

  Online published: 2025-04-28

Abstract

To summarize the nursing experience of a patient with cardiac arrest who underwent emergency percutaneous coronary intervention combined with left ventricular assist device after resuscitation and was transferred to the ICU with left ventricular assist device after surgery. Checklists were used to closely check the steps performed and monitor the process,including daily management,complication observation,weaning and extubation care. The left ventricular assist device was successfully removed after 49.25 h. After 94 hours,the patient was removed from the endotracheal intubation,and after 8 days of ICU treatment,he was transferred to the general ward.

Cite this article

MO Minhua , Lo Wan Po Joanna , Shum Hoi Ping , Chang Li Li . Nursing care of a patient undergoing emergency coronary intervention combined with left ventricular assist device therapy after cardiac arrest[J]. Chinese Journal of Emergency and Critical Care Nursing, 2025 , 6(5) : 570 -572 . DOI: 10.3761/j.issn.2096-7446.2025.05.010

References

[1] Nolan JP, Sandroni C, B?ttiger BW, et al. European resuscitation council and European society of intensive care medicine guidelines 2021:post-resuscitation care[J]. Intensive Care Med, 2021, 47(4):369-421.
[2] Vetrovec GW, Anderson M, Schreiber T, et al. The cVAD registry for percutaneous temporary hemodynamic support:a prospective registry of Impella mechanical circulatory support use in high-risk PCI,cardiogenic shock,and decompensated heart failure[J]. Am Heart J, 2018,199:115-121.
[3] 马贵洲, 徐荣和, 蔡志雄, 等. 复杂高危冠脉病变患者介入治疗现状及进展[J]. 实用医学杂志, 2021, 37(24):3107-3112.
  Ma GZ, Xu RH, Cai ZX, et al. Percutaneous coronary intervention in the treatment of patients with complex,high-risk coronary artery disease[J]. J Pract Med, 2021, 37(24):3107-3112.
[4] Philipson DJ, Cohen DJ, Fonarow GC, et al. Analysis of adverse events related to impella usage(from the manufacturer and user facility device experience and national inpatient sample databases)[J]. Am J Cardiol, 2021,140:91-94.
[5] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 经皮机械循环辅助在复杂心血管疾病介入治疗应用中国专家共识[J]. 中华心血管病杂志, 2022, 50(10):959-972.
  Cardiology Branch of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Chinese expert consensus on clinical application of percutaneous mechanical circulatory support devices in interventional therapy for patients with complex cardiovascular disease[J]. Chin J Cardiol, 2022, 50(10):959-972.
[6] Balthazar T, Vandenbriele C, Verbrugge FH, et al. Managing pa-tients with short-term mechanical circulatory support:JACC review topic of the week[J]. J Am Coll Cardiol, 2021, 77(9):1243-1256.
[7] Riley RF, Henry TD, Mahmud E, et al. SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease[J]. Catheter Cardiovasc Interv, 2020, 96(2):346-362.
[8] Brener SJ, Cunn GJ, Desai PH, et al. A novel risk score to predict one-year mortality in patients undergoing complex high-risk indicated percutaneous coronary intervention(CHIP-PCI)[J]. J Invasive Cardiol, 2021, 33(4):E253-E258.
[9] Basir MB, Kapur NK, Patel K, et al. Improved outcomes associated with the use of shock protocols:updates from the national cardiogenic shock initiative[J]. Cathet Cardio Intervent, 2019, 93(7):1173-1183.
Outlines

/